Aprea TherapeuticsAPRE

13F holders, Q2 2025 (June 30)
23holders −3
1new positions
4sold out
$1.69avg. 13F price*

At the end of Q2 2025, 23 institutions reported holding Aprea Therapeutics Inc. (APRE) in their 13F filings, down 3 from Q1 2025. 1 opened new positions and 4 sold out. The largest holders were AIGH Capital Management LLC ($913K), Sio Capital Management, LLC ($472K) and Sphera Funds Management LTD. ($456K).

Company
Aprea Therapeutics Inc.
CUSIP
03836J201
Latest filing quarter
Q2 2026

History

Number of 13F holders

0102030 Q1 2024: 22Q1 2024Q2 2024: 27Q2 2024Q3 2024: 21Q3 2024Q4 2024: 26Q4 2024Q1 2025: 26Q1 2025Q2 2025: 23Q2 2025Q3 2025: 23Q3 2025Q4 2025: 22Q4 2025Q1 2026: 22Q1 2026Q2 2026: 27Q2 2026

Total Exit/New Position Q1 2025 → Q2 2025

InstitutionsTotal Value
New Positions1$852
Exits4$135K

All 13F filers, Q1 2025 → Q2 2025: 36,820 shares bought and 171,016 shares sold, net −134,196 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 23 holders

AIGH Capital Management LLC 0.43% No change 539,300 $913K
Sio Capital Management, LLC 0.19% Add +1.0% 279,369 $472K
Sphera Funds Management LTD. 0.12% No change 270,000 $456K
Nantahala Capital Management, LLC 0.02% No change 205,760 $348K
Vanguard Group Inc. 0.00% No change 173,842 $296K
DAFNA Capital Management LLC 0.06% No change 137,174 $232K
Morgan Stanley 0.00% Add +93.0% 63,331 $107K
Geode Capital Management, LLC 0.00% No change 43,137 $73K
Landscape Capital Management, L.L.C. 0.00% Reduce -22.4% 23,969 $41K
LPL Financial LLC 0.00% Add +6.2% 17,052 $29K
BNP Paribas Financial Markets 0.00% Add +12.6% 15,432 $26K
Dimensional Fund Advisors LP 0.00% Reduce -13.2% 14,465 $25K
HighTower Advisors, LLC 0.00% No change 13,864 $23K
BlackRock, Inc. 0.00% No change 8,504 $14K
Bank of America Corp. 0.00% Add +0.1% 4,856 $8K
Tower Research Capital LLC (TRC) 0.00% Reduce -10.9% 2,963 $5K
Mb, Levis & Associates, LLC 0.00% No change 806 $1K
Group One Trading LLC 0.00% Reduce -30.0% 577 $981
FMR LLC 0.00% New 501 $852
Osaic Holdings, Inc. 0.00% Add +300.0% 400 $676
WealthCollab, LLC 0.00% No change 158 $268
SBI Securities Co., Ltd. 0.00% No change 40 $68
UBS Group AG 0.00% Add +166.7% 8 $13

"% of holder's portfolio" is APRE's weight in each manager's 13F, not the share of Aprea Therapeutics Inc. the manager owns.